CL2018002646A1 - Prevención de la adherencia del tejido biológico. - Google Patents

Prevención de la adherencia del tejido biológico.

Info

Publication number
CL2018002646A1
CL2018002646A1 CL2018002646A CL2018002646A CL2018002646A1 CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1 CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1
Authority
CL
Chile
Prior art keywords
biological tissue
adhesion
self
prevention
assembling peptide
Prior art date
Application number
CL2018002646A
Other languages
English (en)
Spanish (es)
Inventor
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of CL2018002646A1 publication Critical patent/CL2018002646A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CL2018002646A 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico. CL2018002646A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18

Publications (1)

Publication Number Publication Date
CL2018002646A1 true CL2018002646A1 (es) 2019-07-05

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002646A CL2018002646A1 (es) 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico.

Country Status (11)

Country Link
US (4) US20190091376A1 (cg-RX-API-DMAC7.html)
EP (1) EP3429653B1 (cg-RX-API-DMAC7.html)
JP (1) JP7049557B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190022455A (cg-RX-API-DMAC7.html)
CN (1) CN109152868A (cg-RX-API-DMAC7.html)
AU (2) AU2017232540A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018068941A2 (cg-RX-API-DMAC7.html)
CA (1) CA3017684A1 (cg-RX-API-DMAC7.html)
CL (1) CL2018002646A1 (cg-RX-API-DMAC7.html)
MX (1) MX2018011121A (cg-RX-API-DMAC7.html)
WO (1) WO2017158420A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190091376A1 (en) 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
CN112368295B (zh) 2018-07-03 2025-03-21 立美基股份有限公司 离子性自组装肽
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572964C (en) 2004-07-06 2018-03-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20100102750A (ko) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
CN105435211A (zh) * 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage
US20190091376A1 (en) 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
CN109195640A (zh) 2016-03-18 2019-01-11 立美基股份有限公司 脑脊液漏堵塞
JP2019508175A (ja) 2016-03-18 2019-03-28 株式会社スリー・ディー・マトリックス 膵液瘻の閉鎖

Also Published As

Publication number Publication date
US20230241294A1 (en) 2023-08-03
US20250177614A1 (en) 2025-06-05
JP2019508184A (ja) 2019-03-28
AU2021225225A1 (en) 2021-09-30
US20220111126A1 (en) 2022-04-14
JP7049557B2 (ja) 2022-04-07
EP3429653B1 (en) 2022-11-09
US12377196B2 (en) 2025-08-05
KR20190022455A (ko) 2019-03-06
AU2017232540A1 (en) 2018-09-27
CN109152868A (zh) 2019-01-04
WO2017158420A1 (en) 2017-09-21
MX2018011121A (es) 2019-01-31
US20190091376A1 (en) 2019-03-28
CA3017684A1 (en) 2017-09-21
BR112018068941A2 (pt) 2019-04-16
EP3429653A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
EP3614946A4 (en) DETERMINATION OF THE NATURE OF CONTACT BETWEEN THE CATHETER TIP AND TISSUE
MX2024000348A (es) Mavacamten para su uso en el tratamiento de la cardiomiopatia hipertrofica.
PE20200748A1 (es) Composiciones de aminoacidos para el tratamiento de lesion neuronal
CL2018002644A1 (es) Oclusión fístula pancreática.
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
PL3226854T3 (pl) Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry
MX2015010139A (es) Composicion antiseptica oral para tratamiento de mucositis oral.
CY1120642T1 (el) Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
MX2019005979A (es) Peptidos modificados.
CY1119067T1 (el) Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο
CY1117854T1 (el) Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
MX2019006444A (es) Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
GB2558315A (en) Patterned surfaces
MX2018011121A (es) Prevención de la adherencia de tejido biológico.
MX2020010932A (es) Enzimas quinureninasa humanas y sus usos.
MX384262B (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
MX2022014577A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
EP3787496C0 (en) DETECTION OF IRREGULARITIES IN BREAST TISSUE
ES2514140A1 (es) Uso del inhibidor de sulfatasas esteroideas STX64 para el tratamiento del envejecimiento
MX2019009909A (es) Composiciones farmaceuticas para terapia de combinacion.
CL2018002643A1 (es) Oclusión de fuga de líquido cefalorraquideo.
EP3446723A4 (en) DENTAL TREATMENT MATERIAL AND DENTAL HANDLING KIT
PE20180127A1 (es) Composicion cosmetica reductiva de aplicacion topica que contiene queratina y azufre